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ABSTRACT
Introduction: HIV risk among female entertainment
and sex workers (FESW) remains high and use of
amphetamine-type stimulants (ATS) significantly
increases this risk. We designed a cluster randomised
stepped wedge trial (The Cambodia Integrated HIV and
Drug Prevention Implementation (CIPI) study) to test
sequentially delivered behavioural interventions
targeting ATS use.
Methods and analysis: The trial combines a 12-
week Conditional Cash Transfer (CCT) intervention with
4 weeks of cognitive-behavioural group aftercare (AC)
among FESW who use ATS. The primary goal is to
reduce ATS use and unprotected sex among FESW.
The CCT+AC intervention is being implemented in 10
provinces where order of delivery was randomised.
Outcome assessments (OEs) including biomarkers and
self-reported measures of recent sexual and drug use
behaviours are conducted prior to implementation, and
at three 6-month intervals after completion.
Consultation with multiple groups and stakeholders on
implementation factors facilitated acceptance and
operationalisation of the trial. Statistical power and
sample size calculations were based on expected
changes in ATS use and unprotected sex at the
population level as well as within subjects.
Ethics and dissemination: Ethical approvals were
granted by the Cambodia National Ethics Committee;
University of New Mexico; University of California,
San Francisco; and FHI360. The trial is registered with
ClinicalTrials.gov. Dissemination of process indicators
during the multiyear trial is carried out through annual
in-country Stakeholder Meetings. Provincial ‘Close-Out’
forums are held at the conclusion of data collection in
each province. When analysis is completed,
dissemination meetings will be held in Cambodia with
stakeholders, including community-based discussion
sessions, policy briefs and results published and
presented in the HIV prevention scientific journals and
conferences.
Conclusions: CIPI is the first trial of an intervention
to reduce ATS use and HIV risk among FESW in
Cambodia.
Results: Will inform both CCT+AC implementation in
low and middle-income countries and programmes
designed to reach FESW.
Trial registration number: NCT01835574;
Pre-results.
BACKGROUND
In Cambodia, women engaged in sex work
have consistently been the group with the
Strengths and limitations of this study
▪ This is an experimental study that will assess the
efficacy of combined behavioural interventions to
reduce amphetamine-type stimulant use in
women at high risk of HIV in Cambodia.
▪ The study will investigate the interventions
impact on drug use and sexual risk using both
biomarkers and self-reported data, and the
design allows for analyses that will not be con-
founded by secular trends in these outcomes.
▪ The stepped-wedge design makes implementing
this intervention in 10 randomised provinces
feasible and acceptable in the context of exten-
sive multisectoral coordination because a core
study team provides ongoing support to multiple
implementing partners.
▪ There is a need for ongoing training and study
updates to stakeholders, along with clear mes-
sages that the trial is testing an intervention that
may or may not have the same results as seen
elsewhere.
▪ The study is not designed to assess the interven-
tion impact on HIV incidence.
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highest prevalence and incidence of HIV. In the late
1990s, almost half (45.8%) of the women sampled were
infected, and in 2006, prevalence ranged between 11.7%
and 14.7% depending on work venue (non-brothel vs
brothel based).1–3 Modelling and IgG BED-enzyme
immunoassay studies both indicated that incidence rates
also fell from over 10% annually in 1999 to 1.6% in
2006.1 2 Comprehensive deployment of basic HIV pre-
vention programmes, including condom use promotion,
voluntary counselling and testing, and high coverage of
HIV antiretroviral treatment (ART), have contributed to
these declines among women.4 Sex work remains a high-
risk trade, however, and women engaged in transactional
sex, working in a variety of entertainment and sex work
venues, continue to show high HIV prevalence, inci-
dence and risk.
We conducted two prospective studies of young adult
female entertainment and sex workers (FESW) in
Phnom Penh: the first, the Young Women’s Health
Study-1 (YWHS-1), initiated in 2006, and the second
(YWHS-2) initiated in 2009.3 5 6 Both studies showed
high HIV prevalence, 23% and 15.5%, and incidence,
3.5% and 1.2%, respectively, among these young
women. Notably, our studies showed that amphetamine-
type stimulant (ATS) use, principally in the form of
‘yama’ (ATS in pills) and crystal/ice, was significantly
and independently associated with unprotected sex and
incident sexually transmitted infections (STI).5 6 A large
proportion (40.6%) of FESW report any lifetime use of
ATS, of whom the majority (70.6%) report using before
sex, and 27% report recent use (past 3 months).6 Our
group also examined the social, sexual and occupational
contexts associated with ATS use by young Cambodian
FESWs.7 8 Women engaged in freelance sex work or
working in brothels were more likely to use ATS than
women working in entertainment establishments, who
had higher hazardous levels of alcohol consumption.
Elevated HIV risk among Cambodia FESW is consistent
with studies of stimulant-using populations elsewhere9–11
and underscores the significant need to target ATS use
as a driver of HIV infection in this population.
Non-injection drug use falls outside of conventionally
targeted high-risk behaviours (sexual and injection) in
Cambodia and, as a result, there have been no HIV pre-
vention programmes focused on ATS use as a key risk
factor among FESW or potentially other groups.
Political, economic and social pressures have resulted
in additional new challenges for HIV prevention among
FESW.3 In 2008, the introduction of antitrafficking legis-
lation aimed at suppressing human trafficking and
sexual exploitation amplified risks.3 12 Brothels (previ-
ously acknowledged and engaged in HIV prevention
programming) were closed and police crackdowns
prompted an exodus of brothel-based female sex
workers to entertainment venues and street-based sex
work. In addition to changes in the sex work landscape,
enforcement of the antitrafficking law negatively
impacted on women’s access to HIV and STI prevention
and healthcare services.12 The number of women
engaged in entertainment and sex work also increased
markedly, coinciding with national and global economic
shifts.3 13
Multiple overlapping circumstances contribute to high
HIV risk among Cambodian FESW, including individual
sexual and drug risk exposures, low education and high
poverty levels, and the negative impacts of public policy
and policing. Central to many women’s employment in
entertainment venues is the requirement for highly soci-
able interactions with male customers and, for some
women, this extends to transactional sex as an opportun-
ity for income generation. ATS are used by many women
to stay awake and work longer and see more clients,
which also contributes to HIV risk.6 8 Expanded access
to ART now joins the backbone HIV prevention plat-
form of HIV testing, condom promotion and diagnosis
and treatment of STI as Cambodia aims for HIV elimin-
ation.4 However, if this goal is to be achieved, there
remains a crucial need for innovative prevention
methods that directly target FESW and their multiple
intersecting risks.
The evidence base for effective interventions to
reduce ATS use remains limited; however, the modest
effectiveness of behavioural approaches to reduce stimu-
lant use in developed countries offers an important start-
ing point for countries like Cambodia. Moreover, there
is currently no effective pharmacotherapy for treatment
of ATS dependence, underscoring the need to imple-
ment and test behavioural approaches in this setting.
Behavioural interventions such as conditional cash trans-
fer (CCT) and outpatient cognitive-behavioural sub-
stance abuse treatment are evidence based for reducing
stimulant use.14 15 However, relatively little is known
about the implementation of behavioural interventions
to reduce stimulant use in resource-limited settings like
Cambodia where formal substance abuse treatment is
often unavailable and structural factors are key determi-
nants of ATS use.7 16 The primary aim of this article is to
describe the study design and outcomes chosen to evalu-
ate the effectiveness of an intervention targeting ATS
use and unprotected sex developed as part of a multi-
part HIV prevention platform named the Cambodia
Integrated HIV and Drug Prevention Implementation
(CIPI) programme. We will also describe the operational
challenges encountered in attempting to implement this
large cluster randomised stepped-wedge trial in 10
Cambodian provinces.
Structure and rationale for the interventions
The CIPI programme includes multiple components,
foremost of which is an intervention aimed at reducing
ATS use and concomitant HIV risk. The cluster rando-
mised stepped-wedge design was chosen for this inter-
vention as: (1) it offers a significant logistic advantage
due to the staggered delivery of employing a core study
team, which ensures fidelity to the delivery of interven-
tion while working with multiple NGO partners in the
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different provinces; (2) allows for analyses that will not
be confounded by secular trends in the main outcomes
of interest including consistent condom use or number
of sex partners; and (3) it provides an ethical benefit of
being able to deliver an intervention for which there is
evidence of efficacy to everyone within a rigorous scien-
tific framework. Since provinces serve as their own con-
trols, and comparisons can be made across time and
between groups, temporal effects, which could impact
the study outcomes, can be managed. The intervention
period in each cluster is a total of 16 weeks and includes:
(1) a 12-week CCT intervention where women complete
thrice-weekly urine-screening visits and receive small,
escalating financial incentives for consistent ATS abstin-
ence each week followed by; (2) four once-weekly ses-
sions of cognitive-behavioural group aftercare (AC) for
women who attend at least half (≥18) of the 36 urine-
screening visits during the CCT phase. Adaptation of
CCT and cognitive-behavioural AC was informed by the
Assessment, Decision, Administration, Production,
Topical experts, Integration, Training, and Testing
(ADAPT-ITT) model for tailoring evidence-based HIV
interventions for new target populations17 and has been
described in detail elsewhere.18
Four waves of cross-sectional outcome evaluation (OE)
data collection among FESW are being conducted in
each cluster: one in the month prior to the CCT+AC
intervention implementation and three more at
6-month postintervention intervals following the end of
the 16-week intervention CCT+AC intervention (see
figure 1).
CCT provides tangible incentives as positive reinforce-
ment for behaviour change. CCT has been implemented
broadly to target a range of health and social outcomes
including infant mortality, child health and nutrition,
tuberculosis, vaccination coverage, schooling, child
labour and HIV risk in resource-limited settings.19–26
The documented effectiveness of CCT approaches is
based on the theoretical premise that incentives provide
positive reinforcement to enhance motivation for behav-
iour change and that these incentives may also mitigate
the effects of structural factors, such as food insecurity
and poverty, on negative health outcomes.27
In the substance use treatment field, an extensive lit-
erature has examined the efficacy of ‘contingency man-
agement’, an evidence-based form of CCT where
individuals receive escalating financial reinforcement for
providing biological evidence of drug abstinence.
Founded on basic behavioural principles, contingency
management (henceforth referred to as CCT) yields
clinically meaningful, short-term reductions in stimulant
use and has been used to promote HIV-related health
behaviour change among substance users.14 28–30 CCT
programmes aimed at stimulant users achieve short-term
reduction in stimulant use, which promotes enhanced
retention in other substance abuse treatments and
potentially better overall substance abuse treatment out-
comes.14 31–34
Since CCT is a time-limited behavioural approach,
there is increasing recognition that expanded efforts
may be necessary to support long-term reductions in
ATS use once the financial incentive is removed. As a
result, the CIPI intervention includes a cognitive-
behavioural AC group following the CCT phase to
provide skills for effectively managing triggers for ATS
use. Drawing on prior research highlighting common
change processes that predict better substance abuse
treatment outcomes,35–38 the overarching goals of the
Figure 1 Illustration of cluster randomised stepped-wedge design testing conditional cash transfer and a cognitive-behavioural
aftercare programme.
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cognitive-behavioural AC programme are to: build social
networks that are supportive of abstinence from ATS
use, improve cognitive-behavioural coping skills, and
bolster self-efficacy for managing triggers for ATS use.
The CIPI CCT+AC intervention aims to assist individuals
with achieving clinically meaningful reductions in their
ATS use that will result in lower HIV risk.
The CIPI programme also includes a microenterprise
(ME) opportunity for women who do not use ATS
(identified in OE assessments) or those who successfully
complete CCT+AC. The rationale for including the ME
opportunity into the CIPI programme was to ensure that
all women had a chance to participate in a structural
platform aimed at addressing gender-based poverty, an
evident and critical determinant of HIV risk. By ensur-
ing that this was available to non-ATS users (baseline)
and after the CCT+AC intervention, we also aimed to
safeguard against women using ATS as a means to be
included in this opportunity. The ME opportunity is not
part of the CCT+AC intervention; however, we recognise
the considerable potential for further reductions in HIV
risk among FESW by integrating multiple prevention
approaches into the programme. The ME opportunity
includes a 3-day financial literacy training programme
and the option to apply for a small business loan. ME is
a development tool that has been used to improve a
diverse range of health outcomes in numerous popula-
tions, including reduction of HIV risk behaviours in
FESW.39 Women often engage in sex work because they
lack educational and financial opportunities to explore
other income-generating options. ME may offer oppor-
tunities for women to reduce or cease involvement in
transactional sex as a result of both financial and gender
empowerment, potentially resulting in improved health
outcomes,40–45 reductions in number of sex partners,
and lower rates of unprotected sex.46 Implementation of
ME-based interventions among sex workers in other set-
tings has shown impressive potential for success.46 The
ME opportunity was added to the CIPI programme in
order to assess: (1) the potential engagement of
Cambodian FESW with this structural intervention; and
(2) ME organisations’ interest in using this approach;
however, it is not being evaluated as part of the ATS risk
reduction intervention.
CCT+AC intervention delivery
Eligibility for the 12-week CCT intervention is deter-
mined at the preintervention baseline OE assessment
(s). Using the WHO ASSIST, eligible participants were
required to receive a score of four or higher (ie, >4) on
the ATS specific substance involvement subscale47 and
provide a urine sample that was positive for ATS
(amphetamine or methamphetamine). Women who
have completed the baseline OE and are eligible for
CCT are provided with additional information about the
intervention and an appointment to learn more and
participate in a separate informed consent process. We
use this tiered method of recruitment to support
individual autonomy and minimise any insinuation of
undue influence.
CCT programme: CCT participation includes thrice-
weekly urine screening for 12 weeks (36 possible urine-
screening visits). Participants are encouraged to attend
urine-screening visits at the study field site, but screening
can also be conducted off-site as needed to accommo-
date scheduling challenges that may arise in association
with work or other personal issues. At each urine-
screening visit, participants receive a $2 cash incentive
for providing an ATS negative sample. Escalating cash
bonuses are provided at the end of each week where all
three of the urine samples are negative for ATS: $2 in
weeks 1–4, $4 in weeks 5–8 and $6 in weeks 9–12. The
goal of the cash incentive is to provide an immediate
material positive reinforcement for ATS abstinence, con-
sistent with prior research where more frequent receipt
of cash incentives earned in CCT was associated with
greater odds of abstinence at subsequent urine-
screening visits.48 If participants provide a positive urine
test for ATS, they do not receive the visit incentive or a
cash bonus for that week. Urine testing results are sys-
tematically tracked on a CCT card that provides a visual
representation of each visit’s results. Using the CCT
card, the remaining possible incentive is reviewed with
participants at each urine-screening visit. Total possible
reinforcement for ATS abstinence over the 12 weeks is
$120. (Women report a median income of $US200 per
month (IQR: $120–$300). CCT participation could rep-
resent an additional $10 per week income).
AC group sessions: Women who complete at least half
of the 36 urine-screening visits (ie, ≥18) are eligible to
participate in the cognitive-behavioural AC group,
regardless of their urine test results. On the basis of a
cognitive-behavioural model of treatment for stimulant
use disorders, the principal goals of the 4-session once a
week group AC programme are to: provide and encour-
age women to participate in a supportive social environ-
ment to assist with avoiding ATS use and/or reducing
the harms that they experience related to ATS use, to
provide them with skills that are designed to change
thoughts, feelings and behaviours to more effectively
manage triggers for ATS use, and to bolster self-efficacy
for managing triggers for ATS use.18 The AC sessions
include: (1) group exercises to facilitate cohesion, obser-
vational learning and skill development; (2) skills train-
ing for early recovery and relapse prevention by
managing internal as well as external triggers for ATS
use; (3) meditation and relaxation training and ‘prac-
tice’ techniques for managing negative emotions, trig-
gers and cravings for ATS; and (4) a ‘lucky draw’ as a
positive reinforcement for attendance wherein women
draw a ticket from a prize bowl and can receive a reward
in the form of a cash prize ($10, $5 or $2) or applause
with positive affirmations.49 Prize bowls for each
4-session AC group include a total of 110 tickets, includ-
ing one $10 ticket, 11 $5 tickets, 48 $2 tickets and 50
tickets for applause and positive affirmations from the
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group. Tickets are drawn without replacement. Lucky
draw cash incentives are provided immediately.
ME opportunity delivery
Women who are ATS negative at preintervention base-
line OE (ATS ASSIST score <4 and negative test results
for ATS) and ATS using women who complete enrolled
in CCT+AC and completed all weekly CCT urine-
screening visits in the past 2 weeks of the 12-week pro-
gramme with negative test results for ATS and attended
all four AC sessions, and test negative for ATS at OE-1
are eligible for the ME opportunity.
METHODS
Trial design
The goal of the CIPI intervention is to reduce ATS use
and HIV risk via implementation of an evidence-based
CCT+AC intervention directed at biologically confirmed
ATS users. The trial uses a cluster randomised stepped-
wedge design as illustrated in figure 1 to deliver the
intervention with cluster randomisation at the province
level.50 51 Ten provinces (figure 2) were randomised to 1
of 10 different initiation periods by the study statistician
using a random number generator. Each province will
function as its own control in a time series analysis. The
intervention is conducted at the individual level.
Preintervention baseline (BL-OE) was conducted in
each province prior to CIPI implementation with a goal
of 120 women participating at the first evaluation time
point. The first BL-OE was conducted in June 2013. In
the first four provinces, the BL-OE was conducted twice,
at 3 months and 1-month prior to beginning CCT. In
the subsequent seven provinces, the BL-OE was adminis-
tered only at 1 month prior to CCT initiation. The pre-
intervention or ‘baseline’ wave of data collection was
planned to include 120 eligible women. Using estimates
from our previous research showing that 25% of FESW
actively use ATS,6 we estimated that 30 women would be
eligible for CCT based on results in the baseline OEs.
Analyses will compare OE data collected prior (BL-OE)
to OE data collected and follow the conclusion of the
CCT+AC intervention (OE-1, OE-2 and OE-3).
Figure 3 shows the CONSORT study flow diagram for
the CCT+AC intervention through 30 September 2015.
The 10-province intervention implementation involves
multisectoral collaborative partnerships, and engage-
ment in training and community information sessions,
followed by intervention delivery with preintervention
and postintervention outcome assessments. The inter-
vention was extensively planned with involvement from
numerous community and governmental groups. The
study protocol was informed by qualitative formative
research with FESW regarding the acceptability of the
Figure 2 Map of Cambodia with cluster provinces and randomisation order.
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proposed CCT+AC intervention and barriers and facilita-
tors to trial participation, including incentive amounts,
transportation assistance, directly observed urine speci-
men collection, and the content of the AC programme
described in detail by Dixon et al,16 in a separate report.
Two governmental partners including the Cambodian
Ministry of Health Department of Mental Health and
the National Authority to Combat Drugs were involved
early in protocol planning.
Early in the planning process, a Stakeholder Forum
attended by over 35 governmental and non-
governmental stakeholders was held to review and solicit
input on the proposed project. A CIPI Task Force (TF)
was convened from this meeting, and Terms of
Reference for members were developed to articulate the
purpose and responsibilities of the TF involvement. The
TF meets annually and is apprised regarding the study
progress, as well as to exchange information and feed-
back about health and HIV risk issues relevant to FESW
in Cambodia. Once implementation began, the CIPI
programme was publicised and publicly endorsed by
governmental partners in each province through formal
orientation workshops delivered to stakeholders in each
province prior to or concurrent with implementation
initiation. Stakeholders included local governmental and
health leaders, NGO staff (heads and outreach workers),
as well as police and patient advocates.
Setting
The current widely disseminated model or ‘standard of
care’ programme aimed at reducing HIV risk and HIV
among FESW in Cambodia is called ‘SMARTgirl’.52
Launched nationally in 2009 as a social marketing
health promotion programme aimed at women working
in the high-risk entertainment sector with support from
the President’s Emergency Plan for AIDS Relief
(PEPFAR), SMARTgirl uses targeted communication
tools to promote use of health information, HIV testing,
STI and reproductive health service referral. It is imple-
mented by local NGO. Women are offered ‘member-
ship’, which is free, and have access to a ‘club’ that
serves as a drop-in centre, where they hold events as well
as provide health information and referrals. Integrating
CCT+AC within the activities of the existing SMARTgirl
programme leverages infrastructure that is in place to
reach high-risk women, and positions ATS prevention in
Figure 3 CIPI CCT+AC
Intervention: flow and process
data from 10 Cluster Provinces*.
AC, aftercare; CIPI, Cambodia
Integrated HIV and Drug
Prevention Implementation; CCT,
conditional cash transfer; OE,
outcome assessments.
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an accepted HIV prevention context. Since sex work
and drug use are illegal in Cambodia, this strategy may
potentially reduce the stigma and other negative social
consequences that render drug use interventions diffi-
cult to implement in this setting. The 10 target clusters
(provinces) were chosen on the basis of three criteria:
(1) presence of SMARTgirl HIV prevention activities;
(2) high numbers of FESW enumerated as part HIV pre-
vention programming;53 and (3) moderate to high HIV
prevalence based on data from antenatal surveillance.54
Training
In each province, a designated NGO is responsible for
delivering the SMARTgirl programme. Each of these
partners was engaged to coordinate recruitment and
retention of eligible FESW in the 10 provinces.
Community partners were also engaged in delivering
CCT. Training included the following components deliv-
ered by researchers and staff over 5 days: (1)
Recruitment and retention of high-risk FESW and ATS
using FESW; (2) Administering the study survey and col-
lecting biological specimens (ie, urine samples and
vaginal swabs) during OE assessments; (3) Conducting
CCT urine-screening visits; (4) Delivering brief counsel-
ling messages based on risk profiles from study assess-
ments; and (5) Managing participant data in the field
using computer-based data collection methods.
Inclusion criteria
The target population for CIPI is Cambodian FESW
who: (1) are biologically female; (2) aged ≥18 years; (3)
report≥2 different sexual partners and/or transactional
sex within the past month; (4) understand spoken
Khmer language; and (5) are able to provide voluntary
informed consent. Transactional sex includes exchan-
ging sex for money, goods or social favours. FESW may
work in the entertainment sector, such as in beer
gardens, bars, massage, karaoke and other ‘entertain-
ment’ establishments, as well as in other venues includ-
ing parks and guesthouses. Targeted efforts were
employed to enrol high-risk women, including those
using ATS, although this was not an explicit inclusion
criterion.
Exclusion criteria
The study excludes those who were born male; women
aged less than 18 years (due to employment laws in
Cambodia); women who cannot speak Khmer; women
who are unable to provide informed consent; and those
who report <2 different sexual partners or transactional
sex in the past month.
Recruitment and enrolment
In all provinces, CIPI outreach workers recruited eligible
participants from multiple locations including:
SMARTgirl clubs, entertainment venues and other
locales where FESW are known to congregate or work.
Outreach workers conducted a preliminary verbal
screening for eligibility, provided a basic study descrip-
tion, answered questions, and invited them to attend the
local study site (SMARTgirl Club) for eligibility evalu-
ation and, if interested, study participation.
Transportation to the site was provided or reimbursed
(up to $2). Eligible women who provided informed
consent to participate were asked to provide their finger-
print at the time of initial enrolment using a commer-
cially available digital fingerprint reader that converts
and stores biometric images as an alphanumeric code
(PersonID Fingerprint Identification System,
Bayometric, San Jose, California, USA). The same finger
will yield the same code at subsequent occasions in
>99.9% of cases, and in this study was used to remove
the need for identification at follow-up visits. The code
is not a personal identifier as it cannot be used to recre-
ate a fingerprint.
Data collection
The OEs are conducted prior to and following the CCT
+AC intervention (figure 1). The survey includes self-
reported measures of ATS and alcohol use using the
WHO Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST).47 55 Participants who report
any ATS use or screen positive for an alcohol use dis-
order receive a brief, scripted counselling message from
study staff advising them to reduce or abstain from these
substances as per the WHO ASSIST validation study,
which identified ASSIST scores that maximise sensitivity
and specificity of identifying alcohol and stimulant use
disorders.47 55 56 The survey is administered privately; it
takes approximately 60 min or less, and also collects
information on: socioeconomic indicators, work history
including sex and entertainment work, sexual and drug
use behaviours, use of HIV testing and reproductive
health services, economic well-being, empowerment,
depressive symptoms and self-efficacy.
Biological data collection includes on-site urine testing
for ATS, prostate-specific antigen (PSA) and HIV. Each
participant is instructed on providing a urine specimen
to be tested for ATS metabolites (ie, methamphetamine
and amphetamine). Urine is tested for adulteration
using Specimen Validity Testing (Innovation, Inc, San
Diego, California, USA), and for ATS metabolites using
the Innovacon Multi-Drug Screen Test Panel Dip Kit
(Redwood Toxicology Laboratory, Inc, Santa Rosa,
California, USA). Women are instructed on how to
provide a self-collected vaginal swab for PSA testing, a
reliable biomarker of seminal fluid exposure and bio-
indicator of recent unprotected vaginal sex.57 PSA is
tested for using the OneStep ABAcard p30 rapid PSA
test (Abacus Diagnostics, Inc, West Hills, California,
USA). A rapid HIV antibody test (Determine TM:
HIV1/2; Alere Medical, Co, Ltd, Chiba, Japan) is admi-
nistered twice: at baseline OE and postintervention at
OE 2 (12 months after CCT+AC). HIV testing proce-
dures are in accordance with the Cambodian National
Guidelines and conducted by trained staff; results are
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provided within 30 min of testing. Each participant
receives HIV risk reduction counselling and referrals to
follow up HIV care or other services as needed.
Participants are remunerated in cash in US dollars
(a currency widely used in Cambodia): $4 for participa-
tion, $2 for transportation and offered refreshments and
condoms at the study site. Participants are asked for
basic contact information such as a mobile phone
number and home address so that outreach workers can
remind them of future visit appointments.
Quality assurance
The study has ongoing quality assurance procedures. At
the study headquarters in Phnom Penh, the field-site
supervisor and statistician/data manager perform
regular data verification and protocol compliance
checks. The study supervisor performs on-site monitor-
ing of concluded surveys at each study site for data com-
pleteness, legibility and logical consistency. The
supervisor and data manager also periodically observe
interviews. Research staff from the lead in-country imple-
menter, FHI360, conduct routine monitoring visits to
each province to ensure fidelity to the CCT+AC inter-
vention throughout the study. They are responsible for
compiling numbers of participants recruited, complet-
ing required assessments, maintaining databases and
identifying missing data and missing follow-up assess-
ments. The research assistant prepares recruitment and
missing data reports for weekly review by the study
supervisor. All data are stored on a firewall-protected
server in Cambodia and transferred monthly to the
study statistician at UCSF using secure methods, where it
is reviewed again for consistency and completeness.
Inconsistencies and questions are resolved by reviewing
source documents. Local provincial staff employ several
strategies to achieve the highest retention possible in
OEs, the CCT-AC intervention and the ME programme.
These primarily consist of telephone visit reminders and
calls to reschedule missed visits for those who have an
active phone line, and repeated visits to participants’
home or work locations for visit reminders and in cases
of missed visits. Recruitment, follow-up rates and missing
data are discussed during regular team meetings, and
both investigators and field staff strategise to solve pro-
blems and remedy the shortcomings.
Ethical issues and approvals
The study population is marginalised and engaged in
illegal behaviours and sensitive behavioural and bio-
logical data are being collected. The study is in compli-
ance with ethical principles for human subjects research
promoted by the Declaration of Helsinki developed by
the World Medical Association. Various procedures are
adopted to ensure additional protection for all women
screened and enrolled in the trial including: waiver of
signed informed consent to minimise the risk that any
information may be linked to names and be reported.
The fingerprint reader cannot be linked to personal
identifiers. The consent process is conducted carefully
to ensure that potential participants understand
research objectives, procedures, risks and benefits, reim-
bursement, costs and alternatives, and a short verbal
assessment is conducted to ensure understanding. Very
importantly, the study’s process to include stakeholders
is also a significant step in ensuring protections as local
governmental and health leaders, NGO staff (heads and
outreach workers), as well as police and patient advo-
cates are informed and engaged in the safe and success-
ful implementation of the project. The study team
monitors for adverse events, both physical and social.
The study has a Data Safety and Monitoring Plan and
Board (DSMP; see below).
During the implementation, yearly stakeholder meet-
ings have been held to report on process outcomes.
Provincial ‘Close-Out’ forums are held at the conclusion
of data collection in each province. Study results will be
disseminated after analyses are completed through
various channels, including stakeholder meetings,
community-based discussions, policy briefs, written
reports and publications, national (Cambodian),
regional and international conference venues, and
media releases where appropriate.
Data safety and monitoring
The study has a DSMP and a Data Safety Monitoring
Board (DSMB). The DSMB includes investigators with
experience in women’s health, epidemiology, biostatistics
and HIV prevention in the Southeast Asian region. The
DSMB met three times during the first 18 months of the
trial, and now meets yearly to review reports of study
progress, enrolment and any adverse events that occur.
Reports are also sent to the sponsor at the National
Institute on Drug Abuse.
ANALYSES
The CCT+AC intervention is being implemented and
evaluated using a cluster randomised stepped-wedge
trial design to assess whether the intervention reduces
ATS use and unprotected sex greater than the under-
lying secular trend at the individual and cluster levels.
The primary outcomes being assessed are indicators of
recent (in the past 3 months) risky sexual behaviour: (1)
PSA test results (positive vs negative); (2) self-reported
consistent (always) condom use with recent paying and
non-paying partners during vaginal or anal sex and (3)
self-reported number; and (4) type of sex partners
(paying and non-paying). These were chosen on the
basis of our prior research showing prospective associa-
tions between ATS use and high-risk sexual behaviour.6
Secondary outcomes include: recent ATS use (by self-
report using ASSIST, and urine-based testing), patterns
of ATS use including frequency, quantity and binge use;
and alcohol use (using Audit C and ASSIST). We will
also evaluate associations between CCT+AC and explora-
tory outcomes including: medical and health service use
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(ie, HIV testing history, HIV results, HIV treatment, STI
testing and treatment); visits to reproductive health
clinics, live births, pregnancy terminations in past year,
birth control use; and measures of economic well-being
and empowerment.
Analyses will account for account for potential
within-cluster correlation due to the design using gener-
alised estimating equations. The stepped-wedge approach
can be described as a one-way crossover design with each
randomisation unit spending time in intervention and
control conditions. Analyses will compare outcomes
from data collected preintervention to postintervention,
including assessing the short-term impact (6-months
post-CCT+AC) and to assess durability (12 months and
18 months post-CCT+AC). The effects of the intervention
will be examined using an intent-to-treat approach.
Secondary analyses of as-treated results will be conducted
with data collected on the extent of the CCT+AC inter-
vention participation.
Sample size estimates
We estimated sample size and power on the basis of two
of the primary HIV risk outcomes: (1) number of sex
partners and (2) unprotected sex as measured using
PSA testing. We chose preintervention estimates of these
outcomes based on our previous work.3 5 6 For number
of sex partners, a sample size 600 (300 in CCT and 300
non-CCT) across 10 provinces (clusters) with 60 (with
30 women in CCT) individuals per cluster achieves 80%
power to detect a difference in means of 0.243 between
the groups (or a drop from 1.80 partners/month to 1.56
partners/month) when the SD is 1.0 and the intracluster
correlation is 0.01 using a two-sided t test with a signifi-
cance level of 0.05. For unprotected sex, a sample size of
600 with preintervention and postintervention measure-
ments obtained by sampling 10 clusters with 60 patients
each in a group achieves 80% power to detect a
minimum reduction in the proportion testing positive
for PSA of 8% with a baseline (preintervention) propor-
tion of 22% testing PSA positive. The CCT arm of the
intervention will enrol 300 women or 30 women per
province. Sample size estimates were performed by first
using the formula from a balanced, parallel group
design and then adjusting the values upward by a factor
of 1.44 to account for the decreased efficiency of
the stepped-wedge design due to the unequal allocation
of preintervention and postintervention outcome
assessments.
TRIAL STATUS
The CIPI intervention was initiated in June 2013 with
the first preimplementation OE evaluation survey and
data collection among 120 women recruited in the first
randomised province: Battambang. Four of the 10 pro-
vinces had 2 preimplementation OE assessments; the
remaining 6 provinces had 1 preimplementation OE
(figure 1). As of 30 September 2015, all 10 provinces
have completed preimplementation OE assessments
with a total of 1198 women enrolled (figure 3). The
CCT-AC intervention has initiated in all 10 provinces
with 281 women eligible, and 222 enrolling. The CCT
+AC intervention has been completed in 8 of the 10 pro-
vinces. The first postintervention OE assessment (OE-1)
has been completed in 8 provinces (N=498), the second
(OE-2) in 7 provinces (N=381), and the third and final
evaluation (post-OE) has been completed in 4 provinces
(N=222). Of 288 women eligible for the ME opportunity,
195 (68%) consented to participate (the majority (90%)
non-CCT+AC participants); 178 (91%) completed the
3-day financial literacy training, 38 (21%) applied for
microloans, of whom 27 (67%) were approved and
funded. We anticipate completing data collection in all
provinces by November 2016.
DISCUSSION
Although there is evidence that CCT+AC interventions
can reduce stimulant use, most studies to date have been
conducted in developed countries, and principally
among men who have sex with men.14 34 58–61 To the
best of our knowledge, this is the first study to examine
the effectiveness of this evidence to an intervention
delivered to high-risk women in a resource limited
setting. Given the absence of safe and effective medica-
tion assisted treatments for stimulant use, there is a
strong need for evidence-based behavioural approaches
that have demonstrated effectiveness for ATS users in
other settings and especially in resource-limited ones
such as Cambodia. The CIPI programme is being imple-
mented in close collaboration with multiple stakeholders
including governmental and NGO partners and, if
shown to be effective, has potential for widespread
implementation in the Cambodian context. The cluster
randomised stepped-wedge design has met the logistic
expectation for ease of implementation across the 10
provinces and with multiple partners since the core
study team has been able to travel to each site and
ensure fidelity to the protocol across sites. Community
stakeholders have expressed appreciation that their prov-
ince is receiving the intervention, suggesting that there
are no feelings of inequity. Data collection has not
ended and analyses have not begun on any of the study
outcomes, which has frustrated community partners and
the stakeholders at the yearly meeting, and been chal-
lenging for researchers to address.
Although not a primary outcome of this trial, the
ultimate goal of our intervention is to reduce HIV infec-
tion by decreasing ATS use a key risk factor for
Cambodian FESW. In addition to collecting data on HIV
testing and results over the study period, HIV infection
is being measured at two time points; however, the trial
is not powered to detect differences in HIV incidence
outcomes. By joining the CIPI intervention to the
SMARTgirl programme, which provides support to
women to engage in reducing sexual risk and improving
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reproductive health engagement, our programme has
the potential to add value and impact to an existing pro-
gramme which in 2012 was estimated to reach over
15 000 Cambodian FESW.62 In addition to the outcome
measures described above, we are also tracking program-
matic factors including the number and proportion of
CIPI participants using contraceptive methods, uptake
of family practice screening and subsequent contracep-
tive uptake, and uptake of referrals for HIV, STI testing
and, among women who are HIV-positive, those who
link to clinical services for HIV treatment.
The study implementation includes significant process
and outcome indicators, and a detailed recording of
practice, implementation notes and recruitment assess-
ments. Refusal assessment for the CCT+AC intervention
enrolment, however, is not undertaken systematically. In
brief informal conversations conducted about reasons
for refusal to participate in CCT+AC, the most com-
monly offered reasons included being ‘too busy’, migra-
tion and ‘changing schedule’.
We also encountered challenges in the scheduled
roll-out of the study. Pragmatic considerations including
the Cambodian holiday calendar and local funding
changes to NGOs, which impacted the availability of per-
sonnel, necessitated minor modifications to the trial
timeline. CIPI was initiated 1–3months later than was ini-
tially scheduled in some provinces. Scheduling for the
6-month postintervention OE assessments was not
impacted. The trial design also underwent adaptation in
June 2014, due to cost factors, principally operational
and personnel-related, resulting in eliminating one of
two preimplementation OEs in each province to one
preimplementation OE prior to CCT-AC intervention
delivery. Four provinces had two preimplementation
OEs, and the remaining six had one. This adaptation
did not impact quality control or protocol fidelity as the
intervention was rolled out on the basis of an ongoing
review of process indicators by study researchers.
While there are other evidenced-based interventions
that could be implemented to address ATS use,31 and
unprotected sex63 among FESW, many involve intensive
behavioural treatments that require significant resources
to support implementation and extensive fidelity moni-
toring. The approach used in the CIPI intervention aims
to build on the current key HIV prevention program-
ming for FESW in Cambodia such that implementation
is coupled with existing resources currently in place.52
Use of formative qualitative research and extensive con-
sultation, and collaboration and coordination across
multiple sectors and stakeholders, meant that we were
able to identify and address key concerns and prefer-
ences and to take these into account in developing or
modifying the trial protocol in order to optimise the
acceptability of the intervention and the implementation
of the trial. The stepped-wedge design makes imple-
menting this large-scale intervention feasible and accept-
able in the context of extensive multisectoral
coordination because a core study team provides
ongoing support to multiple implementing partners in
different provinces, and especially as all randomised pro-
vinces receive the intervention, which obviates the need
for designated control provinces and potential commu-
nity concerns about equity and ethical issues. Even
without a control group, the study team has to be very
clear that the project is testing an intervention that may
or may not have the same results seen elsewhere. The
workshops and stakeholder meetings have been essential
to providing this information in an ongoing manner.
Importantly, CIPI is the first trial assessing the impact
of a CCT+AC intervention in reducing drug use and
HIV risk to be conducted in Asia. In resource-limited set-
tings like Cambodia, CCT and time-limited, cognitive-
behavioural interventions represent potentially scalable
approaches to reducing ATS use and optimising HIV/
AIDS prevention efforts. Results from the CIPI CCT+AC
intervention have the potential to inform the science of
HIV and drug prevention implementation in low and
middle-income countries to achieve an AIDS-free
generation.
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